RENAISSANCE TECHNOLOGIES LLC

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1037389 NEW YORK, NY

Position in LYEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,829,169

-$506,035 QoQ

Shares Held

130,190

+11.8% QoQ

Ownership

0.531%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 87 holders

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. LYEL ranks #141 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,829,169	130,190	+11.8%	Shares	Sole	2026-08-13
2026-03-31	$2,335,204	116,411	+194.8%	Shares	Sole	2026-05-14
2025-12-31	$1,215,502	39,490	-38.3%	Shares	Sole	2026-02-12
2025-09-30	$1,039,197	63,990	-4.8%	Shares	Sole	2025-11-13
2025-06-30	$593,959	67,190	-96.2%	Shares	Sole	2025-08-13
2025-03-31	$951,453	1,768,500	+9.7%	Shares	Sole	2025-05-14
2024-12-31	$1,031,773	1,612,146	+716.7%	Shares	Sole	2025-02-13
2024-09-30	$272,412	197,400	+29.6%	Shares	Sole	2024-11-13
2024-06-30	$220,835	152,300	-64.0%	Shares	Sole	2024-08-09
2024-03-31	$944,405	423,500	+484.1%	Shares	Sole	2024-05-13
2023-12-31	$140,650	72,500	+78.1%	Shares	Sole	2024-02-13
2022-09-30	$298,331	40,700	-18.9%	Shares	Sole	2022-11-14
2022-06-30	$327,304	50,200	-6.2%	Shares	Sole	2022-08-12
2022-03-31	$270,175	53,500	—	Shares	Sole	2022-05-13
No filing history on record for this holder in this stock.